Arabic translation and validation of the dementia knowledge assessment scale (DKAS-A) and public knowledge assessment in the United Arab Emirates

阿拉伯语版痴呆症知识评估量表(DKAS-A)及阿联酋公众知识评估的翻译和验证

阅读:1

Abstract

Dementia is a neurocognitive disorder affecting millions, with prevalence projected to triple by 2050. Assessing dementia knowledge is crucial for its prevention, diagnosis, and treatment. This study developed the Arabic version of the Dementia Knowledge Assessment Scale (DKAS-A) to facilitate this evaluation. We conducted a cross-sectional study among adults in the United Arab Emirates (UAE) between December 2023 and January 2024. We collected participants’ data using a sociodemographic form and the DKAS, which was translated into Arabic using the Translation, Review, Adjudication, Pretest, and Documentation (TRAPD) method. We verified the translation’s validity, internal consistency, and reliability. The DKAS-A demonstrated acceptable internal consistency (Cronbach’s alpha = 0.7), very strong equivalence to the original English tool (Pearson’s correlation coefficients > 0.8), and moderate test-retest reliability (intraclass correlation coefficient = 0.67). Confirmatory Factor Analysis (CFA) supported a revised 21-item version for the DKAS-A. Of 912 participants, 405 completed the Arabic version of the questionnaire. Only 22.8% demonstrated moderate knowledge of dementia. Higher knowledge levels were significantly associated with female gender, involvement in the medical field, higher education, and experience with People with Dementia (PwD). The DKAS-A was successfully developed and validated. The inadequate dementia knowledge in the UAE necessitates the development of a national dementia plan to raise awareness and decrease the disease’s burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-025-27528-2.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。